Zymeworks was founded in 2003 by Dr. Ali Tehrani and Dr. Jayarama Akkiraju. We have a proven track record in drug discovery, research, development, and clinical validation as recognized through multiple regulatory and partnering milestones. Zymeworks enables the development of novel therapeutics that are designed for improved pharmacological activity, immunogenicity and safety, multi-efficacy and manufacturability.
